The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, Chemours Company’s stock clocked out at $12.73, up 3.08% from its previous closing price of $12.35. In other words, the price has increased by $3.08 from its previous closing price. On the day, 4.41 million shares were traded. CC stock price reached its highest trading level at $12.855 during the session, while it also had its lowest trading level at $12.328.
Ratios:
To gain a deeper understanding of CC’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.83 and its Current Ratio is at 1.75. In the meantime, Its Debt-to-Equity ratio is 7.57 whereas as Long-Term Debt/Eq ratio is at 7.39.
On January 28, 2025, Truist started tracking the stock assigning a Buy rating and target price of $27.
UBS Upgraded its Neutral to Buy on July 09, 2024, whereas the target price for the stock was revised from $28 to $30.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 02 ’25 when Gumpel Damian bought 13,400 shares for $9.22 per share. The transaction valued at 123,548 led to the insider holds 123,879 shares of the business.
Gumpel Damian bought 7,822 shares of CC for $77,828 on Jun 03 ’25. The insider now owns 131,701 shares after completing the transaction at $9.95 per share. On May 19 ’25, another insider, HOSTETTER SHANE, who serves as the Chief Financial Officer of the company, bought 4,450 shares for $11.28 each. As a result, the insider paid 50,196 and bolstered with 59,694 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CC now has a Market Capitalization of 1905349888 and an Enterprise Value of 5631769600. As of this moment, Chemours’s Price-to-Earnings (P/E) ratio for their current fiscal year is 61.86, and their Forward P/E ratio for the next fiscal year is 5.20. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.92. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.33 while its Price-to-Book (P/B) ratio in mrq is 3.29. Its current Enterprise Value per Revenue stands at 0.973 whereas that against EBITDA is 7.877.
Stock Price History:
The Beta on a monthly basis for CC is 1.58, which has changed by -0.42424244 over the last 52 weeks, in comparison to a change of 0.1185931 over the same period for the S&P500. Over the past 52 weeks, CC has reached a high of $25.54, while it has fallen to a 52-week low of $9.13. The 50-Day Moving Average of the stock is 12.61%, while the 200-Day Moving Average is calculated to be -20.31%.
Shares Statistics:
It appears that CC traded 4.13M shares on average per day over the past three months and 6407410 shares per day over the past ten days. A total of 149.57M shares are outstanding, with a floating share count of 148.55M. Insiders hold about 0.75% of the company’s shares, while institutions hold 97.01% stake in the company. Shares short for CC as of 1749772800 were 14332924 with a Short Ratio of 3.47, compared to 1747267200 on 13285385. Therefore, it implies a Short% of Shares Outstanding of 14332924 and a Short% of Float of 14.08.
Dividends & Splits
With its trailing 12-month dividend rate of 1.0, CC has a forward annual dividend rate of 0.84. Against a Trailing Annual Dividend Yield of 0.08097166The stock’s 5-year Average Dividend Yield is 4.05.
